Lung Cancer Trial, Recruiting NCT06322329 Sponsor: Region Stockholm Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT06322329
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been approved to receive a specific type of radiation treatment (called SBRT) for one or more tumors in the lower part of your lungs (either lung cancer or cancer that has spread to the lungs from elsewhere).
  • You are 18 years old or older.
  • You are able to lie still in one position for at least 30 minutes.
  • You can read and understand Swedish well enough to read study information and fill in a questionnaire.

Who may not be able to join:

  • You are pregnant, breastfeeding, or planning to become pregnant or breastfeed during the treatment period.
  • You have a medical reason why you cannot have an MRI scan (for example, certain metal implants or a pacemaker — confirm with trial site).
  • You are otherwise unable to take part in the study for any other reason (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Region Stockholm
Registry
ClinicalTrials.gov
Start date
15 March 2024
Est. completion
17 March 2026

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Difference in amplitude of the tumour motion, as assessed by dynamic MRI and 4D CT, respectively; Difference in amplitude of the tumour motion, assessed at different times (using dynamic MRI and 4D CBCT); Difference in the structure of the probability density function, assessed at different times

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov